The expression level of MUM1 can have prognostic implications in various malignancies. For example, high MUM1 expression in DLBCL is often associated with a poorer prognosis and may indicate a more aggressive disease course. Conversely, in some contexts, MUM1 expression might correlate with better outcomes, depending on the specific type of lymphoma and other molecular characteristics of the tumor.